NYSE: CHCT
Community Healthcare Trust IncCIK 0001631569 · SIC 6798 · Real Estate Investment Trusts
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (IMMR 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade CHCT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 4, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations (Unaudited)
(Unaudited; Dollars and shares in thousands, except per share amounts)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| REVENUES | ||||
| Rental income | 30,971 | 30,128 | 62,240 | 59,858 |
| Other operating interest | 253 | (1,043) | 508 | (695) |
| 31,224 | 29,085 | 62,748 | 59,163 | |
| EXPENSES | ||||
| Property operating | 5,865 | 5,585 | 12,234 | 11,680 |
| General and administrative (1) | 4,890 | 10,559 | 9,998 | 15,659 |
| Depreciation and amortization | 10,738 | 10,879 | 21,395 | 21,822 |
| 21,493 | 27,023 | 43,627 | 49,161 | |
| OTHER (EXPENSE) INCOME | ||||
| Gains on sale, net of loss and impairment of real estate assets | 46 | 640 | — | 640 |
| Interest expense | (7,428) | (6,592) | (14,227) | (12,944) |
| Credit loss reserve | — | (8,672) | — | (8,672) |
| Deferred income tax benefit | 12 | — | 12 | — |
| Interest and other income, net | 3 | 5 | 6 | 8 |
| (7,367) | (14,619) | (14,209) | (20,968) | |
| NET INCOME (LOSS) | 2,364 | (12,557) | 4,912 | (10,966) |
| Net income (loss) per common share Basic & Diluted | 0.06 | (0.50) | 0.12 | (0.47) |
| Weighted Average Common Shares Outstanding- Basic & Diluted | 27,016 | 26,803 | 27,004 | 26,768 |
| ___________ | ||||
| (1) General and administrative expenses for the three and six months ended June 30, 2026 included stock-based compensation expense totaling approximately $2.8 million and $5.5 million, respectively. General and administrative expenses for the three and six months ended June 30, 2025 included severance and transition-related expenses totaling $1.3 million and non-cash stock-based compensation expense totaling approximately $7.1 million and $9.8 million, respectively, each including accelerated amortization of $4.6 million related to the termination of a former executive officer. See Note 9 – Stock Incentive Plan. | ||||
Condensed Consolidated Balance Sheets
(Dollars and shares in thousands, except per share amounts)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Real estate properties | ||
| Land and land improvements | 163,506 | 154,673 |
| Buildings, improvements, and lease intangibles | 1,077,295 | 1,047,743 |
| Personal property | 814 | 813 |
| Total real estate properties | 1,241,615 | 1,203,229 |
| Less accumulated depreciation | (301,593) | (280,316) |
| Total real estate properties, net | 940,022 | 922,913 |
| Cash and cash equivalents | 2,673 | 3,340 |
| Assets held for sale, net | — | 5,265 |
| Other assets, net | 60,900 | 59,239 |
| Total assets | 1,003,595 | 990,757 |
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||
| Liabilities | ||
| Debt, net | 559,321 | 532,199 |
| Accounts payable and accrued liabilities | 17,691 | 14,925 |
| Other liabilities, net | 12,341 | 14,246 |
| Total liabilities | 589,353 | 561,370 |
| Commitments and contingencies | ||
| Stockholders' Equity | ||
| Preferred stock, $0.01 par value; 50,000 shares authorized; none issued and outstanding | — | — |
| Common stock, $0.01 par value; 450,000 shares authorized; 28,655 and 28,471 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 287 | 285 |
| Additional paid-in capital | 722,454 | 717,450 |
| Cumulative net income | 95,689 | 90,777 |
| Accumulated other comprehensive income | 9,047 | 6,691 |
| Cumulative dividends | (413,235) | (385,816) |
| Total stockholders’ equity | 414,242 | 429,387 |
| Total liabilities and stockholders' equity | 1,003,595 | 990,757 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(Unaudited; Dollars in thousands)
| Description | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net income (loss) | 4,912 | (10,966) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 21,395 | 21,822 |
| Other amortization | 792 | 544 |
| Stock-based compensation | 5,489 | 5,241 |
| Accelerated amortization of stock-based compensation | — | 4,591 |
| Straight-line rent receivable | (1,351) | (1,823) |
| Gain on sales, net of loss and impairment of real estate assets | — | (640) |
| Credit loss reserve | — | 8,672 |
| Changes in operating assets and liabilities: | ||
| Other assets | 1,246 | 1,668 |
| Accounts payable and accrued liabilities | 402 | 558 |
| Other liabilities | (1,612) | (1,459) |
| Net cash provided by operating activities | 31,273 | 28,208 |
| INVESTING ACTIVITIES | ||
| Acquisitions of real estate | (28,514) | (9,711) |
| Proceeds from sale of real estate | 6,276 | 615 |
| Proceeds from the repayment of notes receivable | 300 | 4,975 |
| Capital expenditures on existing real estate properties | (9,153) | (8,911) |
| Net cash used in investing activities | (31,091) | (13,032) |
| FINANCING ACTIVITIES | ||
| Net borrowings on revolving credit facility | 27,000 | 14,000 |
| Dividends paid | (27,419) | (26,645) |
| Taxes paid on behalf of employees and shares withheld upon shares vesting | (398) | (1,735) |
| Equity issuance costs | (32) | (317) |
| Net cash used in financing activities | (849) | (14,697) |
| (Decrease) Increase in cash and cash equivalents | (667) | 479 |
| Cash and cash equivalents, beginning of period | 3,340 | 4,384 |
| Cash and cash equivalents, end of period | 2,673 | 4,863 |
| Supplemental Cash Flow Information: | ||
| Interest paid (net of capitalized interest) | 13,704 | 12,420 |
| Invoices accrued for construction, tenant improvement, and other capitalized costs | 7,723 | 4,148 |
| Reclassification between other assets and proceeds from sale of real estate | 664 | — |
| Reclassification of registration statement costs to equity issuance costs | 85 | 121 |
| Increase (decrease) in fair value of cash flow hedges | 4,494 | (4,876) |
| Income taxes paid | 80 | 20 |
| Capitalized interest | 111 | 80 |
Amounts as printed on the EDGAR/iXBRL face — (Unaudited; Dollars and shares in thousands, except per share amounts); (Dollars and shares in thousands, except per share amounts); (Unaudited; Dollars in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗